Evaluating HbA1c as a Prognostic Indicator in COVID-19 Patients

Authors

  • Dr Palak Patel , Dr. Bhoomika Patel , Dr. Sandip Patel , Dr. Himanshu Patel Author

DOI:

https://doi.org/10.48047/

Keywords:

Keywords: COVID-19, Diabetes mellitus, Glycated hemoglobin, HbA1c, Hypertension, Inflammation

Abstract

Background: Diabetes mellitus has been widely recognized as a significant risk factor influencingthe prognosis of COVID-19, with patients exhibiting poorer outcomes and higher mortality rates. However, the role of pre-COVID-19 glycemic control in determining the severity of the disease and clinical outcomes remains a subject of ongoing investigation.

Downloads

Download data is not yet available.

Downloads

Published

2025-02-19

Issue

Vol. 16 No. 2 (2025): Volume 16 issue 2 (2025)

Section

Articles